Search

Objective: To evaluate whether the efficacy of Getong Tongluo Capsule (葛酮通络胶囊, GTC, consisted of total flavone of Radix Puerariae) on improving patients' quality of life and lowering blood pressure are superior to the extract of Ginkgo biloba (EGB) for patients with convalescent-phase ischemic stroke and primary hypertension. Methods: This randomized, positive-drug- and placebo-controlled, double-blind trial was conducted from September 2015 to October 2017. Totally 477 eligible patients from 18 hospitals in China were randomly assigned in a 2:1:1 ratio to the following interventions, twice a day for 12 weeks: (1) GTC 250 mg plus EGB-matching placebo 40 mg (237 cases, GTC group), (2) EGB 40 mg plus GTC-matching placebo 250 mg (120 cases, EGB group) or (3) GTC-matching placebo 250 mg plus EGB-matching placebo 40 mg (120 cases, placebo group). Moreover, all patients were orally administered aspirin enteric-coated tablets 100 mg, once a day for 12 weeks. The primary outcome was the Barthel Index (BI). The secondary outcomes included the control rate of blood pressure and National Institutes of Health Stroke Scale (NIHSS) scores. The incidence and severity of adverse events (AEs) were calculated and assessed. Results: The BI relative independence rates, the clinical recovery rates of NIHSS, and the total effective rates of NIHSS in the GTC and EGB groups were significantly higher than the placebo group at 12 weeks after treatment (P<0.05), and no statistical significance was found between the GTC and EGB groups (P>0.05). The control rate of blood pressure in the GTC group was significantly higher than the EGB and placebo groups at 12, 18 and 24 weeks after treatment (P<0.01). There were no statistically significant differences in the incidences of AEs, adverse drug reactions, or serious AEs among the 3 groups (P>0.05). Conclusion: GTC exhibited significant efficacy in improving patients' quality of life as well as neurological function and controlling hypertension. (Registration No. ChiCTR1800016667) [ABSTRACT FROM AUTHOR]

The Tianhuashan Basin is one of the most important volcanic basins in the northern Wuyi, southeastern China, comprising two successive volcanic units, the Daguding Formation and the overlying Ehuling Formation, along with several small associated igneous intrusions. The Lengshuikeng super-large-scale Ag-Pb-Zn deposit, which is closely related to these volcanic-intrusive rocks, is located in the northwestern part of the basin. In order to understand the basin evolution and magmatism, we determined LA-ICP-MS U-Pb zircon ages for the volcanic successions and associated intrusive rocks. U-Pb zircon dating of volcanic units yielded precise ages of 144±1 Ma for crystal tuff in the lower member of the Daguding Formation, 142±1 Ma for andesite within the upper member of the Daguding Formation, 140±1 Ma for tuffite of the first (i.e., lowermost) member of the Ehuling Formation, and 137±1 Ma for rhyolitic ignimbrite within the third volcano-stratigraphic member of the Ehuling Formation. Three types of intrusive igneous rocks (quartz syenite porphyry, K-feldspar granite porphyry, and rhyolite porphyry) yielded precise weighted mean 206Pb/238U ages of 144±1, 140±1, and 140±1 Ma, respectively, suggesting that these intrusions along with the aforementioned volcanics were all emplaced during the Early Cretaceous. In addition, the weighted mean Pb/U ages determined on zircon from two samples of a granite porphyry intrusion, which hosts ore mineralization of the Lengshuikeng Ag-Pb-Zn deposit, are 158±1 and 157±1 Ma, indicating emplacement in the Late Jurassic. These new geochronological results for igneous rocks of the Tianhuashan Basin constrain the timing of volcanic and plutonic activity in the basin, and have important implications for our understanding the tectonic history of the region, and for identifying metallogenic types and the timing of ore deposition of the Lengshuikeng deposit. [ABSTRACT FROM AUTHOR]

Scarlet fever has resurged in China starting in 2011, and the environment is one of the potential reasons. Nationwide data on 655,039 scarlet fever cases and six air pollutants were retrieved. Exposure risks were evaluated by multivariate distributed lag nonlinear models and a meta-regression model. We show that the average incidence in 2011–2018 was twice that in 2004–2010 [RR = 2.30 (4.40 vs. 1.91), 95% CI: 2.29–2.31; p < 0.001] and generally lower in the summer and winter holiday (p = 0.005). A low to moderate correlation was seen between scarlet fever and monthly NO2 (r = 0.21) and O3 (r = 0.11). A 10 μg/m3 increase of NO2 and O3 was significantly associated with scarlet fever, with a cumulative RR of 1.06 (95% CI: 1.02–1.10) and 1.04 (95% CI: 1.01–1.07), respectively, at a lag of 0 to 15 months. In conclusion, long-term exposure to ambient NO2 and O3 may be associated with an increased risk of scarlet fever incidence, but direct causality is not established. The reason for a re-emergence of scarlet fever in China remains unclear. Here the authors show that the number of scarlet fever cases surged in 2011 peaking in 2018, this correlates with an increase in NO2 and O3 but does not necessarily imply causation. [ABSTRACT FROM AUTHOR]